Nwk Group, Inc. Amarin Corp Plcuk Transaction History

Nwk Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $7,242 - $11,050	-1,700 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $8,484 - $11,151	-2,100 Reduced 55.26%	1,700 $8,000
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $6,214 - $10,738	1,300 Added 52.0%	3,800 $26,000
Q1 2020 May 12, 2020	BUY	$4.0 - $21.53 $1,200 - $6,459	300 Added 13.64%	2,500 $10,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $30,668 - $53,064	2,200 New	2,200 $47,000

183

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $298M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.